EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)
Conditions: Acute Decompensated Heart Failure Interventions: Device: Reprieve Decongestion Management System; Drug: Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide) Sponsors: Reprieve Cardiovascular, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Conditions: Heart Failure, Congestive Interventions: Drug: Furosemide; Drug: Torsemide; Drug: Bumetanide; Drug: sacubitril/valsartan; Drug: Hydralazine; Drug: Isosorbide Dinitrate Sponsors: Heart Center Research, LLC; Boston Scientific Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Bumetanide in Patients With Alzheimer's Disease
Condition: Alzheimer Disease Interventions: Drug: Bumetanide; Drug: Placebo Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Bumetanide in Patients With Alzheimer's Disease
Conditions: Alzheimer Disease Interventions: Drug: Bumetanide; Drug: Placebo Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study of Ultra High Dose Diuretics to Treat Heart Failure
Condition: Heart Failure; With Decompensation Interventions: Drug: Bumetanide; Drug: Furosemide Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials
